A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression

A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression

Abstract Background Early progression after the first-line R-CHOP treatment leads to a very dismal outcome and necessitates alternative treatment for patients with diffuse large B-cell lymphoma (DLBCL). This study aimed to develop a genetic predictive model for early progression and evaluate its pot...

Full description

Bibliographic Details
Main Authors: Jialin Ma, Zheng Yan, Jiuyang Zhang, Wenping Zhou, Zhihua Yao, Haiying Wang, Junfeng Chu, Shuna Yao, Shuang Zhao, Peipei Zhang, Yuanlin Xu, Qingxin Xia, Jie Ma, Bing Wei, Shujun Yang, Kangdong Liu, Yongjun Guo, Yanyan Liu
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Biomarker Research
Subjects:
Diffuse large B-cell lymphoma
Early progression
CD79B
PIM1
Online Access:http://link.springer.com/article/10.1186/s40364-020-00214-3

Internet

http://link.springer.com/article/10.1186/s40364-020-00214-3

Similar Items